Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular 'Direct‐to‐Biology' Screening.
Saved in:
| Title: | Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular 'Direct‐to‐Biology' Screening. |
|---|---|
| Authors: | Wilders, Harry1,2,3 (AUTHOR), Biggs, George2 (AUTHOR), Rowe, Sam M.1 (AUTHOR), Cawood, Emma E.2 (AUTHOR), Riziotis, Ioannis G.2 (AUTHOR), Rendina, Alan R.4 (AUTHOR), Grant, Emma K.1 (AUTHOR), Pettinger, Jonathan1,2 (AUTHOR), Fallon, David J.1 (AUTHOR), Skehel, Mark5 (AUTHOR), House, David1,2 (AUTHOR), Tomkinson, Nicholas C. O.3 (AUTHOR), Bush, Jacob T.1,2,3 (AUTHOR) Jacob.x.bush@gsk.com |
| Source: | Angewandte Chemie. 2/3/2025, Vol. 137 Issue 6, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
